Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Bayer’s FXIa inhibitor asundexian reduces ischemic stroke risk without increasing major bleeding

18/04/2026 Published by vivi

Bayer has announced the publication of full results from the Phase III OCEANIC-STROKE study in The New England Journal of... Read more

Tags: #Global Trends

UCB pivots to cell therapy with $1.2B acquisition of Neurona Therapeutics

18/04/2026 Published by vivi

Belgian pharmaceutical giant UCB announced on Friday its acquisition of Neurona Therapeutics for up to $1.2 billion. The move highlights... Read more

Category: Uncategorized

Tags: #M&A

Implementation of the new sanction framework to tighten administrative management in healthcare

18/04/2026 Published by vivi

The Ministry of Health has recently issued an implementation plan for Decree No. 90/2026/ND-CP (signed on March 30, 2026) regarding... Read more

Category: Uncategorized

Tags: #Vietnam

Vir Biotechnology completes Astellas deal to advance prostate cancer immunotherapy

18/04/2026 Published by vivi

Vir Biotechnology has officially entered into a global strategic collaboration with Astellas Pharma. The agreement focuses on the co-development and... Read more

Category: Uncategorized

Tags: #M&A

Terremoto secures $108M in Series C to advance next-generation AKT inhibitor programs

17/04/2026 Published by vivi

Terremoto Biosciences has successfully closed a $108 million Series C financing round. The capital will be utilized to push its... Read more

Category: Uncategorized

Tags: #Global Trends

Roche to launch new trial for Elevidys following European regulatory setback

17/04/2026 Published by vivi

Swiss drugmaker Roche has announced plans to initiate a new global Phase 3 clinical trial for Elevidys. This move is... Read more

Category: Uncategorized

Tags: #Global Trends

Former Deputy Surgeon General nominated as next CDC Director

17/04/2026 Published by vivi

On April 16, President Trump tapped Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC). If confirmed... Read more

Category: Uncategorized

Tags: #Global Trends

Kailera nets $625M in one of the biotech sector’s largest-ever IPOs

17/04/2026 Published by vivi

On April 16, Kailera Therapeutics, an obesity drug developer, announced it had raised $625 million in its initial public offering... Read more

Category: Uncategorized

Tags: #Global Trends

Eli Lilly releases updated safety data for Foundayo following FDA request

17/04/2026 Published by vivi

Following the recent approval of Foundayo (orforglipron), the U.S. Food and Drug Administration (FDA) is mandating a series of post-approval... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 15 Page 16 Page 17 … Page 121 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members